Thiol/Disulphide Homeostasis in Unexplained Infertility

April 21, 2023 updated by: Serif Aksin, Siirt University

The Role of Thiol/Disulphide Homeostasis in Unexplained Primary Infertile Patients

The aim in this study is to determine whether there is a relationship between Thiol / Disulphide levels in primary infertile patients and comparing them with infertile patients and the control group. For this purpose, 41 women followed up with the diagnosis of primary infertility in Siirt Training and Research Hospital between November 2022 and January 2023 will be included in the study. The same number of (n:41) non-infertile control women will be included. Age, pregnancy history and medical history of both groups will be recorded. FSH, LH, E2, TSH, and prolactin levels taken routinely in these patients will be examined. Thiol/disulphide levels in the blood will be checked by taking whole blood from these patients. In the light of the information thus obtained, the investigator plan to determine whether there is a relationship between oxidant/antioxidant balance in primary infertile patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Reactive oxygen species (ROS) are products of normal cellular metabolism and consist of oxygen ions, free radicals and peroxides. Adding an electron to oxygen creates the superoxide anion radical, which can then be converted to a hydroxyl radical, peroxyl radical, or hydrogen peroxide. Free radicals try to participate in chemical reactions that free themselves of their unpaired electrons and result in oxidation. Natural antioxidants found in the body include catalase, glutathione peroxidase, superoxide dismutase and glutathione reductase, vitamins C and E, ferritin, and transferrin. Other lifestyle factors such as smoking, diet, illness, pollution, stress, alcohol, and allergies also contribute to increased levels of free radicals, suggesting that these factors have a negative impact on female fertility, potentially through the formation of excessive oxidative stress.

Excessive accumulation of ROS can damage cells, proteins, DNA and lipids; therefore, ROS levels are regulated by antioxidant mechanisms in the organism. A shift in the direction of ROS in this balance is called oxidative stress (OS). ROS produced in the follicle have important roles in folliculogenesis and ovulation. Granulosa cells produce antioxidants to protect oocytes from the harmful effects of excess ROS. OS has been implicated as an etiopathogenetic factor in female infertility. The number of studies examining the role of OS in the etiopathogenesis of infertility has increased in recent years, and it has been suggested that increased OS and/or decreased antioxidant defense mechanisms may contribute to infertility-related conditions.

One of the defense mechanisms against OS in humans is the thiol redox reaction. The thiol consists of a sulfhydryl group, and under OS conditions these functional groups form reversible disulfide bridges. These bonds bring about functional and structural changes in proteins. Disulfide bonds are reduced to thiol groups through antioxidant mechanisms, thereby providing thiol/disulfide homeostasis. Thus, disulfide bridges are thought to be a marker of OS, while thiols are suggested to be members of the antioxidant system. Only one side of this equilibrium has been measured by Ellman (1979), whereas in recent years both sides of the thiol/disulfide equilibrium can be measured by the Erel and Neselioğlu assay method, allowing a full assessment of the thiol/disulfide status.

Dynamic thiol/disulfide homeostasis, a recently identified marker of OS, is thought to have critical roles in pathological processes in various vital processes such as folliculogenesis and ovulation.

n the literature review, there are studies investigating the relationship between infertility and oxidant/antioxidants. However, measurements require measuring a large number of parameters and many separate biomarkers. The thiol/disulfide balance is beneficial in terms of showing the oxidant/antioxidant balance in total. It was not possible to measure this balance simultaneously on both sides in the method measuring the thiol/disulfide balance by Newman in 1979. In recent years, it has become possible to measure the serum Thiol/disulfide balance bilaterally with the automatic spectrophotometric method described by Erel and Neşelioğlu. This study aims to investigate whether there is a relationship by measuring the Total oxidant/antioxidant load with the Thiol/disulfide method in patients with unexplained infertility, to investigate the relationship between thiol/disulfide homeostasis and impaired ovulation and fertility, and to analyze the potential pathogenetic mechanism.

Study Type

Observational

Enrollment (Actual)

82

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Siirt, Turkey, 56000
        • Siirt Üniversity Medical Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Women between the age of 18-35 diagnosed with infertility of unknown cause.

Description

Inclusion Criteria:

  • Patients diagnosed with primary infertility
  • Patients between the age of 18-35

Exclusion Criteria:

  • Active hypertension
  • Chronic liver or kidney failure history
  • Coronary artery disease
  • Acute infection (within 14 days)
  • Any chronic inflammatory disease
  • Presence of autoimmune disease
  • Known malignancy
  • Inflammatory bowel disease
  • Hormonal contraception
  • Smoking
  • alcohol use
  • Drug use
  • Patients with tubal infertility
  • Partner with abnormal spermiogram

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Women diagnosed with primary infertility (n:41)
Women which followed up with infertility of unknown cause.
Thiol/disulphide levels in the blood will be checked by taking complete blood count
Control group ( n:41)
Healthy women who are not infertile
Thiol/disulphide levels in the blood will be checked by taking complete blood count

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the total oxidant/antioxidant load with the Thiol/disulfide method in patients with unexplained infertility
Time Frame: "through study completion, an average of 4 months
To determine whether there is a relationship between oxidant/ antioxidant balance in primary infertile patients by looking at Thiol/disulphide blood levels in both groups.
"through study completion, an average of 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2022

Primary Completion (Actual)

April 21, 2023

Study Completion (Actual)

April 21, 2023

Study Registration Dates

First Submitted

November 7, 2022

First Submitted That Met QC Criteria

November 16, 2022

First Posted (Actual)

November 29, 2022

Study Record Updates

Last Update Posted (Actual)

April 25, 2023

Last Update Submitted That Met QC Criteria

April 21, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SiirtUNIVERSI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on complete blood count

3
Subscribe